SEOUL-SEMICONDUCTOR
Seoul Semiconductor Co., Ltd. (“Seoul”) (KOSDAQ 046890), a leading global innovator of LED products and technology, announced the introduction of its next-generation WICOP UHL (Ultra High Luminance) Series LEDs, which reduce headlamp power consumption up to 20% for electric vehicles, with an improvement of heat dissipation performance up to 40%. The company will begin mass production in 2021 and with promotions to key customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201015005428/en/
Battery power consumption is one of the important requirements that determine the range of an electric vehicle, or the driving distance on a single charge. In order to reduce the power consumption, it is critical to reduce the overall weight of automobile parts.
The next-generation “WICOP UHL” Series LEDs exhibit up to 40% better heat dissipation performance than other products in the current LED market. By applying WICOP UHL to automobile headlamps, the weight of lamp heat sink structure can be reduced by 75%. The LED emitting area of the product is extremely small approximately 0.5mm2 , which enables a slim headlamp design. This new LED technology completely compensates for the disadvantages of heat dissipation, as the lighting emitting area is smaller, and thus it enables not only slim lamp design but also high performance.
WICOP (Wafer Integrated Chip on PCB), a fundamental technology of the new product, is the world’s first patented package-less LED technology developed by Seoul Semiconductor. Unlike flip chip technology that must be bonded in the semiconductor process, WICOP LEDs can be easily surface-mounted (SMT) in the general substrate bonding process. Mini LEDs also use the WICOP technology with a robust structure.
“This new product will be mass-produced from 2021 according to requests of global headlamp manufacturers. And it can be adopted for headlamps of all automobile brands and designs,” said representative of Seoul Semiconductor.
Seoul will showcase the WICOP UHL Series products at the Shanghai International Auto Lamp Exhibition (ALE), scheduled for October 15 – 16 in Shanghai, China.
About Seoul Semiconductor
Seoul Semiconductor is the world’s second-largest global LED manufacturer, a ranking excluding the captive market, and has more than 14,000 patents. Based on a differentiated product portfolio, Seoul offers a wide range of technologies, and mass produces innovative LED products for indoor and outdoor lighting, automotive, IT products, such as mobile phone, computer displays, and other applications, as well as the UV area. The company’s world’s first development and mass production products are becoming LED industry standard and leading the global market with a package-free LED, WICOP; a high-voltage AC-driven LED, Acrich; an LED with 10X the output of a conventional LED, nPola; a cutting edge ultraviolet clean technology LED, Violeds; an all direction light emitting technology, filament LED; a natural spectrum LED, SunLike; and more. For more information, please visit www.seoulsemicon.com/en .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201015005428/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn12.11.2025 19:00:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine, to its Scientific Advisory Board (SAB). This strategic addition strengthens Brenus’ international SAB as the company advances its proprietary Stimulated Ghost Cell (SGC) platform and lead candidate STC-1010 toward its next clinical milestones. Globally recognized for her groundbreaking contributions to cancer immunology, Prof. Finn has led major discoveries in tumor antigens. She identified the MUC1 tumor antigen, a cornerstone in cancer research, and discovered cyclin B1 as a promising target for anti-cancer immunotherapy. Over her career, she has authored more than 220 peer-reviewed publications and co-led extensive clinical trials across pancreatic, colon, breast, prostate, and lung cancers. She also served as President of the American Associa
Telcoin Makes U.S. Banking History with Approval to Launch the First Regulated Digital Asset Bank12.11.2025 19:00:00 CET | Press release
Charter approval allows Telcoin Digital Asset Bank to establish a bridge between traditional banking and decentralized finance, including the creation of eUSD as the nation’s first bank-issued stablecoin. Telcoin today announced its final charter approval from the Nebraska Department of Banking and Finance to launch Telcoin Digital Asset Bank, the first Digital Asset Depository Institution in the United States. The charter positions Telcoin to become the first true blockchain bank, directly connecting U.S. bank accounts to regulated “Digital Cash” stablecoins. Its flagship product, eUSD, will be the first bank-issued, on-chain U.S. dollar stablecoin, offering consumers and businesses a secure, compliant way to use Digital Cash for payments, remittances, and savings. Notably, it is also the first bank charter to explicitly authorize connecting U.S. consumers to DeFi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112119122
Mindbreeze Named a Leader in the IDC MarketScape: Worldwide General-Purpose Knowledge Discovery Software 2025 Vendor Assessment12.11.2025 18:01:00 CET | Press release
Mindbreeze, a leading global provider of AI-based knowledge management solutions, has been named a Leader in the IDC MarketScape: Worldwide General-Purpose Knowledge Discovery Software 2025 Vendor Assessment (doc #US53011225, November 2025). In the IDC MarketScape 14 vendors of knowledge discovery software were evaluated. For the assessment, IDC divided potential key measures for success into two primary categories: capabilities and strategies. Get your complimentary copy of the excerpt here. The IDC MarketScape notes, “Companies looking for reliable, context-aware insights from internal and external sources should consider Mindbreeze. The platform enables decision making for compliance, risk management, and strategic planning, appealing to business areas such as customer service, finance, legal, and HR. It can tailor pre-built search applications to specific departments for search while supporting broader knowledge management and digital workspace initiatives.” "We are proud to be rec
Ardian Set to Mobilize Development Finance Institutions (DFIs) With European Investment Bank (EIB), Proparco and British International Investment (BII) for a €100m Commitment for Its Nature-Based Solutions Strategy12.11.2025 17:12:00 CET | Press release
Ardian’s Nature-Based Solutions strategy is dedicated to investing in projects in reforestation, wetlands and mangrove restoration intended to protect biodiversity. The strategy aims at providing carbon credit to corporates in their decarbonisation strategy. It will enable the sequestration of 85 million tons of carbon from the atmosphere over a 40 year’ period. European Investment Bank commits €50m and Proparco €20m and British International Investment intend to commit €10m, reflecting increasing DFIs appetite in the sector. Ardian, a world-leading private investment firm, today announces that it has secured commitment from several Development Finance Institutions (DFIs), the European Investment Bank (EIB) and Proparco. British International Investment (BII) have signaled their intention to provide commitment to the Nature Based Solutions fund. Total fund commitments will stand for a total of c. €100m by year end to Ardian’s Nature-Based Solutions (NBS) strategy. As anchor investors,
ViTAA Medical Secures FDA 510(k) Clearance for AiORTA™ Plan — Marking the First Step in Its Hyper-Precise Aortic Care Platform12.11.2025 16:00:00 CET | Press release
FDA clearance marks a pivotal milestone in ViTAA’s broader AiORTA™ suite, designed to support physicians across the full continuum of aortic care ViTAA Medical Solutions Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for AiORTA™ Plan, the company’s fully automated, hyper-precise aortic surgery planning solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112394413/en/ This clearance represents a key milestone in the evolution of ViTAA’s broader AiORTA™ platform, built to support physicians across the full continuum of aortic care. ViTAA’s additional innovations—AiORTA™ Maps and AiORTA™ Watch—are currently in multicenter clinical studies, progressing rapidly toward future clinical release. A Leap Forward in Aortic Surgery Planning Built to automate key preoperative measurements and streamline aortic case prep, AiORTA™ Plan generates a complete aortic plan in minutes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom